小分子RNA与新兴的青光眼视神经保护方法

发布时间：2018-01-07 09:00

  本文关键词：小分子RNA与新兴的青光眼视神经保护方法　出处：《中国临床药理学杂志》2015年04期 　论文类型：期刊论文

  更多相关文章： 小分子RNA 神经节细胞 视神经保护

【摘要】：青光眼是一种致盲率高且不可逆转的眼病,常表现为眼内间断或持续性眼压升高,进而引起视神经及视功能损害。随着近年来诊断水平的不断提高,科学技术的不断进步,一类特征性小分子RNA及其在转录调节中的作用机制被广泛研究报道,其被有效地运用在青光眼视神经保护,已成为研究热点。
[Abstract]:Glaucoma is a kind of ocular disease with high blindness rate and irreversibility. It is often characterized by intraocular discontinuity or persistent elevation of intraocular pressure, which leads to the damage of optic nerve and visual function. With the improvement of diagnostic level in recent years. With the development of science and technology, a class of characteristic small molecule RNA and its mechanism in transcriptional regulation have been widely reported, which has been effectively applied to the protection of glaucoma optic nerve and has become a hot research topic.
【作者单位】： 首都医科大学附属北京同仁医院国家药物临床试验机构;
【基金】：十二五“重大新药创制”国家科技重大专项基金资助项目
【分类号】：R775
【正文快照】： (首都医科大学附属北京同仁医院国家药物临床试验机构,北京100730)SONG Si-yue,ZHAO Xiu-li(National Institute for Drug ClinicalTrial,Beijing Tongren Hospital,Capital Medical University,Beijing100730,China)青光眼是导致人类失明的三大致盲性眼病之一,虽然各种类型的，

本文编号：1391852